• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management



Studies show that people treated with Botox (botulinum toxin, type A) for chronic migraine report less frequent, less intense headaches, and new data show that the use of Botox for headache prevention can reduce the number of emergency room visits by as much as 50 percent, according to Andrew Blumenfeld, M.D., chief of neurology at Kaiser Permanente in San Diego.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.